Skip to content

Surgical versus conservative treatment of LC1 pelvic fractures in the elderly

Lateral compression type-1 fracture fixation in the elderly, a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16478561
Enrollment
600
Registered
2019-04-08
Start date
2019-08-02
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral compression type-1 pelvic fracture Injury, Occupational Diseases, Poisoning Fracture of lumbar spine and pelvis

Interventions

Eligible and consenting patients will be randomly allocated to either surgical fixation or non-operative management. Surgical fixation: Surgical fixation of the pelvic fracture using INFIX, an anter

Sponsors

Barts Health NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 26/03/2021: 1. Aged 60 years or older 2. LC-1 pelvic fracture arising from a low-energy fall from standing height or less 3. Patient unable to mobilise independently to a distance of around 3 m and back, due to pelvic pain (or perceived pelvic pain) 72 h after injury. Use of a walking aid and verbal guidance are permitted, however physical assistance is not. Courtesy telephone call/postcard sub-study: All participants recruited into the L1FE trial who consent to being contacted by telephone and by post will be eligible for the sub-study. There are no additional inclusion or exclusion criteria _____ Previous inclusion criteria: 1. Aged 60 years or older 2. An LC-1 pelvic fracture is diagnosed, arising from a low energy fall 3. After 72 hours post-injury the patient is unable to mobilise independently or with supervision (with or without a walking aid) to a distance of around 3 meters and back, due to pelvic pain or perceived pelvic pain Courtesy telephone call/postcard sub-study: All participants recruited into the L1FE trial who consent to being contacted by telephone and by post will be eligible for the sub-study. There are no additional inclusion or exclusion criteria

Exclusion criteria

Exclusion criteria: Current inclusion criteria as of 26/03/2021: 1. Surgery not able to be conducted within 10 days of injury 2. Surgery is contra-indicated because patient is not fit for anaesthetic (spinal or general) or soft tissue concerns 3. Patients who were non-ambulatory or required physical assistance to walk, prior to their injury (use of a walking aid is permitted) 4. Concomitant injury or poly-trauma that impedes mobilisation 5. Fracture configurations not amenable to internal fixation using INFIX, with or without ilio-sacral screws 6. Patients who test positive for COVID-19 within 72 h of admission (applicable only where testing is standard of care) Courtesy telephone call/postcard sub-study: There are no additional exclusion criteria for the courtesy telephone call sub-study _____ Previous exclusion criteria: 1. Unable to perform surgery within 10 days of injury 2. Surgery is contra-indicated because patient is not fit for anaesthetic (spinal or general) or soft tissue concerns 3. Patients who were non-ambulatory or required assistance walking, with or without a walking aid prior to their injury 4. Concomitant injury or poly-trauma that impedes mobilisation 5. Fracture configurations that the surgeon feels are not amenable to internal fixation using INFIX, with or without adjunctive ilio-sacral screws Courtesy telephone call/postcard sub-study: There are no additional exclusion criteria for the courtesy telephone call sub-study

Design outcomes

Primary

MeasureTime frame
Average patient quality of life over the study time period, assessed by the patient-reported outcome measure, EuroQol 5 Dimensions (5L) utility score (EQ-5D-5L). The EQ-5D-5L is a validated generic patient-reported outcome measure (www.euroqol.org), including validation in patients with hip fractures and orthopaedic patients with cognitive impairment.; Timepoint(s): baseline, 2 weeks, 6 weeks, 12 weeks, 6-month time points as well as an optional 12 month follow up point for those recruited early within the study.

Secondary

MeasureTime frame
1. Physical function measured using Patient Reported Outcome Measures Information System (PROMIS) Lower Extremity Function at baseline, 2 weeks, 6 weeks, 12 weeks, 6 months 2. Physical function measured using Timed Up and Go Test (TUG) at 12 weeks 3. Mental health measured using PROMIS Scale v1.2 – Global Health Mental 2a at baseline, 2 weeks, 6 weeks, 12 weeks, 6 months 4. Pain measured by Numeric Rating Scale (NRS) at baseline, 2 weeks, 6 weeks, 12 weeks, 6 months 5. Delirium measured using Abbreviated Mental Test Score (AMTS) at baseline, 2 weeks, 12 weeks 6. Delirium measured using 4AT Rapid Assessment Test for Delirium at baseline, 2 weeks, 12 weeks 7. Complications measured using clinic review and/or patient self-report at 2 weeks, 12 weeks, 6 months 8. Mortality measured identified using central NHS records at 12 weeks, 6 months, 12 months (for those patients that agree to this additional follow-up) 9. Imaging - radiologic assessment of the pelvis performed at 12 weeks 10. Other outcomes: data on length of hospital stay, change of place of residence (e.g. own home to residential care home) and return to normal activities, measured using clinic review and/or patient self-report at 2 weeks, 6 weeks, 12 weeks, 6 months

Countries

England, Scotland, United Kingdom, Wales

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 10, 2026